Collegium to Present at Upcoming Investor Conferences
September 06 2017 - 7:00AM
Collegium Pharmaceutical, Inc. (Nasdaq:COLL) today announced that
management will present at the following investor conferences in
September:
- The 19th Annual Rodman & Renshaw Global Investment
Conference on Monday, September 11th at 12:05 p.m. ET at the Lotte
New York Palace Hotel
- The Cantor Fitzgerald Global Healthcare Conference on Monday,
September 25th at 4:45 p.m. ET at the InterContinental New York
Barclay Hotel
About Collegium Pharmaceutical,
Inc.
Collegium is a specialty pharmaceutical company focused on
developing a portfolio of products that incorporate its proprietary
DETERx® technology platform for the treatment of chronic pain and
other diseases. The DETERx technology platform is designed to
provide extended-release delivery, unique abuse-deterrent
properties, and flexible dose administration options.
About Xtampza ER
Xtampza® ER is Collegium’s first product utilizing the DETERx
technology platform. Xtampza ER is an abuse-deterrent,
extended-release, oral formulation of oxycodone approved by the FDA
for the management of pain severe enough to require daily,
around-the-clock, long-term opioid treatment and for which
alternative treatment options are inadequate.
Contact:
Alex Dasalla
adasalla@collegiumpharma.com
Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From Aug 2024 to Sep 2024
Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From Sep 2023 to Sep 2024